Biotechnology
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. Mike Blake | Reuters Eli Lilly on Tuesday reported first-quarter adjusted profit that topped Wall Street’s expectations and hiked its full-year guidance on strong sales of its blockbuster diabetes drug Mounjaro and newly launched weight loss […]
Read More
Walmart to shutter health centers, virtual care service in latest failed push into health care
Walmart on Tuesday said it will close all of its health-care clinics across the country, a stunning reversal of its plans to bring its low-priced reputation to the dentist and doctor’s office along with the grocery aisle. The big-box retailer said it would also shutter its telehealth provider, which it acquired for an undisclosed amount […]
Read More
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson‘s and Bristol Myers Squibb‘s legal challenges to the Biden administration’s Medicare drug-price negotiations, ruling that the program is constitutional. The decision is another win for the White House in a bitter legal fight with several drugmakers […]
Read More
‘This is a exclusive time’: ARK Invest’s chief futurist tackles tech innovation from AI to robotics
ARK Invest’s main futurist lists five groups that should really give tech investors an edge. In accordance to Brett Winton, robotics, synthetic intelligence, multi-omics sequencing, general public blockchain and power storage are vital regions due to the fact they’re all getting into the marketplace at the very same time. “We believe that this is a […]
Read More
A CVS pharmacy in Vegas becomes first to join new national pharmacy union
The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on February 7, 2024. Patrick T. Fallon | AFP | Getty Images A CVS in Las Vegas has become the first location to join a new national pharmacy union, a milestone as organizers try to help […]
Read More
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Pavlo Gonchar | Lightrocket | Getty Images The Food and Drug Administration on Friday approved Pfizer‘s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B […]
Read More
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its blockbuster blood thinner Eliquis and several new drugs posted sales growth. But the pharmaceutical company swung to […]
Read More
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products. The pharmaceutical giant also raised and narrowed its […]
Read More
Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said it will start to work directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader expansion of its specialty […]
Read More
Biogen tops profit estimates as cost cuts take hold, Alzheimer’s drug Leqembi launch picks up
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported first-quarter profit that topped estimates as the company’s cost-cutting efforts took hold and sales of its closely watched Alzheimer’s drug, Leqembi, came in higher than expected. Biogen and […]
Read More